Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
  • Research
    • Research
    • Publications
    • Global Research Centers
    • Case Development
    • Initiatives & Projects
    • Research Services
    • Seminars & Conferences
    →
  • Publications→

Publications

Publications

Filter Results: (1,299) Arrow Down
Filter Results: (1,299) Arrow Down Arrow Up

Show Results For

  • All HBS Web  (1,299)
    • People  (4)
    • News  (227)
    • Research  (904)
    • Events  (4)
    • Multimedia  (7)
  • Faculty Publications  (496)

Show Results For

  • All HBS Web  (1,299)
    • People  (4)
    • News  (227)
    • Research  (904)
    • Events  (4)
    • Multimedia  (7)
  • Faculty Publications  (496)
← Page 26 of 1,299 Results →

    Gerald Zaltman

    *Joined Harvard Faculty: 1991
    Prior Faculty Appointments: Northwestern University, 1968-75;
    University of Pittsburgh, 1975-91

    *Doctoral Degree in Sociology Received from: The John Hopkins University;
    MBA Degree Received from: The University of... View Details

    Keywords: pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals
    • 14 Sep 2023
    • Research & Ideas

    Working Moms Are Mostly Thriving Again. Can We Finally Achieve Gender Parity?

    employees at the same time,” McGinn says. The kids are OK McGinn and colleagues’ 2019 work put new context around the age-old career-versus-stay-at-home debate. Across two multinational datasets spanning 29 countries and two decades, they... View Details
    Keywords: by Kara Baskin
    • September 2010 (Revised July 2013)
    • Case

    Alnylam Pharmaceuticals: Building Value from the IP Estate

    By: Willy C. Shih and Sen Chai
    The learning objective of this case is to help students recognize the interplay between intellectual property (IP) rights and corporate strategy. We do this by examining what is a fairly atypical circumstance today in which a single firm is able to secure what it... View Details
    Keywords: Patents; Lawsuits and Litigation; Rights; Competitive Strategy; Corporate Strategy; Pharmaceutical Industry; Pharmaceutical Industry; United States
    Citation
    Educators
    Purchase
    Related
    Shih, Willy C., and Sen Chai. "Alnylam Pharmaceuticals: Building Value from the IP Estate." Harvard Business School Case 611-009, September 2010. (Revised July 2013.)
    • 26 Apr 2004
    • Research & Ideas

    A Clear Eye for Innovation

    is Ciba Vision. Established in the early 1980s as a unit of the Swiss pharmaceutical giant Ciba-Geigy (now Novartis), the Atlanta-based Ciba Vision sells contact lenses and related eye-care products to optometrists and consumers. Although... View Details
    Keywords: by Charles A. O'Reilly III & Michael L. Tushman
    • Person Page

    Julie Battilana's Most Recent Columns for "Le Monde"

    By: Julie Battilana

    Julie Battilana is a regular contributor to the French newspaper "Le Monde." Below are her most recent articles.

    Where are the Political Ideas Being Produced?

    July, 16 2014

    Click View Details

    • February 2006 (Revised November 2012)
    • Case

    Corporate Responsibility & Community Engagement at the Tintaya Copper Mine (A)

    By: V. Kasturi Rangan, Brooke Barton and Ezequiel Reficco
    Located in the highlands of Peru, the Tintaya copper mine has long been a source of intense conflict between local community members and mine operators. The mine, which was owned and managed first by the Peruvian state and later by BHP Billiton, stands on 2,300... View Details
    Keywords: Developing Countries and Economies; Multinational Firms and Management; Agreements and Arrangements; Corporate Social Responsibility and Impact; Business and Community Relations; Non-Governmental Organizations; Conflict Management; Mining Industry; Australia; Peru
    Citation
    Educators
    Purchase
    Related
    Rangan, V. Kasturi, Brooke Barton, and Ezequiel Reficco. "Corporate Responsibility & Community Engagement at the Tintaya Copper Mine (A)." Harvard Business School Case 506-023, February 2006. (Revised November 2012.)
    • Program

    Senior Executive Leadership Program—China

    including: Large, established companies, either private or state-owned Entrepreneurial ventures—either new companies or new ventures within established companies Growing family businesses View Details
    • December 2023 (Revised February 2024)
    • Case

    21Seeds: Taking Shots at Breakout Growth

    By: Elie Ofek, Julian De Freitas, Michael Moynihan and Nicole Tempest Keller
    21Seeds, a female-founded flavor-infused tequila startup launched in 2019, had made inroads into the alcoholic beverage industry by focusing on an underserved consumer segment in spirits—women, primarily in their 30s and 40s, many of whom were moms—and by following a... View Details
    Keywords: Mergers and Acquisitions; Business Startups; Growth and Development Strategy; Brands and Branding; Product Positioning; Distribution Channels; Sales; Food and Beverage Industry
    Citation
    Educators
    Purchase
    Related
    Ofek, Elie, Julian De Freitas, Michael Moynihan, and Nicole Tempest Keller. "21Seeds: Taking Shots at Breakout Growth." Harvard Business School Case 524-008, December 2023. (Revised February 2024.)
    • March 2023 (Revised March 2023)
    • Case

    Roche: Innovation and Access to Healthcare

    By: George Serafeim, Susanna Gallani and Benjamin Maletta
    In May 2022, Roche Group, one of the largest healthcare companies in the world, hosted its first investor event focused exclusively on its efforts to impact access to healthcare. While Roche had recently set an ambitious goal to double the number of patients that had... View Details
    Keywords: ESG (Environmental, Social, Governance) Performance; Sustainable Finance; Growth Strategy And Execution; Sustainability Targets; Impact Evaluation; Healthcare Access; Healthcare Innovation; Healthcare Systems; Healthcare Operations; Finance; Strategy; Health Testing and Trials; Health Care and Treatment; Growth Management; Measurement and Metrics; Innovation Strategy; Corporate Social Responsibility and Impact; Pharmaceutical Industry; Pharmaceutical Industry; Switzerland; North America; Europe; Asia; Latin America; Africa
    Citation
    Educators
    Purchase
    Related
    Serafeim, George, Susanna Gallani, and Benjamin Maletta. "Roche: Innovation and Access to Healthcare." Harvard Business School Case 123-075, March 2023. (Revised March 2023.)
    • 14 Nov 2011
    • Research & Ideas

    Creating a Global Business Code

    Phases After publishing the final results of the multinational survey, the team plans to explore more focused research on companies headquartered in emerging markets such as Brazil, India, China, and Russia.... View Details
    Keywords: by Carmen Nobel
    • May 2023
    • Case

    Legacy Partners

    By: Royce Yudkoff and Richard S. Ruback
    Stephen Holbrook and Austin Pulsipher (both HBS '19) had been leading Nutrishare since acquiring the company six months earlier in mid-2021. The company, based in Sacramento CA, was a compounding pharmacy serving Total Parenteral Nutrition ("TPN") patients nationwide.... View Details
    Keywords: Acquisition; Growth and Development Strategy; Competitive Strategy; Business or Company Management; Pharmaceutical Industry
    Citation
    Educators
    Purchase
    Related
    Yudkoff, Royce, and Richard S. Ruback. "Legacy Partners." Harvard Business School Case 223-092, May 2023.
    • 11 Apr 2023
    • Op-Ed

    The First 90 Hours: What New CEOs Should—and Shouldn't—Do to Set the Right Tone

    and the way unexpected crises can emerge rapidly, leaders must move faster and display more strategic agility than ever before. Much of Watkins’ advice about how company officials should assume a leadership post still holds true. It’s... View Details
    Keywords: by John Quelch
    • February 2020
    • Case

    Leading Change in Talent at L'Oréal

    By: Lakshmi Ramarajan, Vincent Dessain and Emer Moloney
    Jean-Claude Le Grand just stepped into a new role as Executive Vice-President for Human Resources at the global cosmetics company, L’Oréal. He is now responsible for the hiring, development, promotion, and retention of 83,000 employees worldwide. The highly successful... View Details
    Keywords: Advertising; Business Headquarters; Business Divisions; Business Organization; Change; Change Management; Transformation; Competency and Skills; Experience and Expertise; Talent and Talent Management; Demographics; Diversity; Gender; Nationality; Multinational Firms and Management; Human Resources; Employees; Recruitment; Retention; Selection and Staffing; Innovation and Management; Jobs and Positions; Employment; Human Capital; Leadership; Leadership Development; Leadership Style; Leading Change; Management Practices and Processes; Marketing; Brands and Branding; Product Marketing; Organizations; Organizational Change and Adaptation; Organizational Structure; Personal Development and Career; Planning; Strategic Planning; Problems and Challenges; Networks; Social Psychology; Attitudes; Power and Influence; Social and Collaborative Networks; Business Strategy; Advertising Industry; Beauty and Cosmetics Industry; Consumer Products Industry; France; Paris
    Citation
    Educators
    Purchase
    Related
    Ramarajan, Lakshmi, Vincent Dessain, and Emer Moloney. "Leading Change in Talent at L'Oréal." Harvard Business School Case 420-106, February 2020.
    • 10 Sep 2008
    • Research & Ideas

    Long-Tail Economics? Give Me Blockbusters!

    you can make money in many creative industries by selling specialized products to niche markets identified via the Internet. For example, the new CEO of GlaxoSmithKline, the pharmaceuticals giant, likens the search for blockbusters to... View Details
    Keywords: by John Quelch; Pharmaceutical; Pharmaceutical
    • February 2002
    • Case

    Fighting AIDS and Pricing Drugs

    By: John T. Gourville
    In early 2001, makers of AIDS drugs were suing to prevent developing countries from violating their patents. The issue was driven by price. The developing countries could not afford the market price for these drugs. At the same time, the drug companies were reluctant... View Details
    Keywords: Developing Countries and Economies; Patents; Price; Strategy; Globalized Markets and Industries; Pharmaceutical Industry
    Citation
    Educators
    Purchase
    Related
    Gourville, John T. "Fighting AIDS and Pricing Drugs." Harvard Business School Case 502-061, February 2002.
    • Web

    Technology & Operations Management - Faculty & Research

    with multinational enterprises’ (MNEs’) labor standards. Analyzing audit data from thousands of Chinese suppliers, we find that suppliers in cities with more wage-related activism increased compliance with MNEs’ wage-related standards but... View Details

      John T. Gourville

      John Gourville is the Albert J. Weatherhead, Jr. Professor of Business Administration at the Harvard Business School.  He joined the HBS Marketing Unit in 1995 after receiving his Ph.D. at the University of Chicago in marketing and behavioral research.  His most... View Details

      Keywords: pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals
      • 11 Aug 2003
      • Research & Ideas

      Cheap, Fast, and In Control: How Tech Aids Innovation

      experimentation and are triggering fundamental changes in R&D processes and performance in such fields as integrated circuit design, automotive development, and pharmaceutical drug discovery. Computer modeling and simulation, rapid... View Details
      Keywords: by Wendy Guild
      • Web

      Africa - Global

      other stakeholders where Prof. Macomber discussed his work on climate adaptation. Prof. Macomber’s research focuses on how companies and governments can integrate climate resilience into real estate and infrastructure projects to manage... View Details
      • November 2007
      • Case

      Antegren: A Beacon of Hope

      By: Joshua D. Margolis, Thomas J. DeLong and Terence Heymann
      The CEO of Biogen Idec faces a set of difficult decisions regarding a promising drug for Multiple Sclerosis that is headed for early approval by the FDA. The first in a series focuses on operational decisions triggered by the drive for early approval. Sparks discussion... View Details
      Keywords: Demand and Consumers; Leadership; Ethics; Corporate Social Responsibility and Impact; Decision Choices and Conditions; Crisis Management; Health Testing and Trials; Pharmaceutical Industry; Pharmaceutical Industry
      Citation
      Educators
      Purchase
      Related
      Margolis, Joshua D., Thomas J. DeLong, and Terence Heymann. "Antegren: A Beacon of Hope." Harvard Business School Case 408-025, November 2007.
      • ←
      • 26
      • 27
      • …
      • 64
      • 65
      • →
      ǁ
      Campus Map
      Harvard Business School
      Soldiers Field
      Boston, MA 02163
      →Map & Directions
      →More Contact Information
      • Make a Gift
      • Site Map
      • Jobs
      • Harvard University
      • Trademarks
      • Policies
      • Accessibility
      • Digital Accessibility
      Copyright © President & Fellows of Harvard College.